13 results
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
17 Jan 24
Current report (foreign)
4:30pm
and the Parent Termination Payment contemplated by the Merger Agreement with respect to obtaining any regulatory clearance would incentivize the parties to work … regulatory clearance and approval as provided in the Merger Agreement, and such termination payment would sufficiently incentivize Parent to use its
F-3/A
GRCL
Gracell Biotechnologies Inc
12 Sep 23
Shelf registration (foreign) (amended)
4:12pm
to employees, directors and consultants to incentivize their performance and align their interests with ours. In addition, our shareholders and board
F-3
GRCL
Gracell Biotechnologies Inc
24 Aug 23
Shelf registration (foreign)
4:03pm
and restated in October 2020, for the purpose of granting share-based compensation awards to employees, directors and consultants to incentivize
20-F
34ung9bql1 bxwldo
23 Apr 21
Annual report (foreign)
4:04pm
424B4
cfy sia7ebw
8 Jan 21
Prospectus supplement with pricing info
1:42pm
F-1/A
0hsjyq7wy
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
lqs69mh3dtg4l
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
4d80ca0x53k hk
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
oz6htq sy7jaeb
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
cuc3hoyis
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
yj0yone7c
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next